BEIJING and SHANGHAI and BOSTON, Oct. 15, 2025 /PRNewswire/ -- Jacobio Pharma (1167.HK) today announced that its subsidiary, Beijing Jacobio Pharmaceuticals Co., Ltd. ("Beijing Jacobio"), has entered ...
CEO Pablo Legorreta emphasized a strong start to 2025, highlighting 12% growth in Royalty Receipts and a 17% increase in Portfolio Receipts, driven by the company's diversified portfolio and milestone ...
Ascendis Pharma (ASND) has released an update. Ascendis Pharma A/S has structured its capital to enable significant growth opportunities, with a current share capital of DKK 60,642,144. The company ...
Royalty Pharma's stock has underperformed recently, down 7% year to date while the S&P500 has climbed 13%. In the company's latest Q2'24 results, Royalty Pharma reported a 12% increase in portfolio ...
Innate Pharma SA ( (FR:IPH)) has shared an announcement. On December 22, 2025, Innate Pharma reported that as of December 18, 2025, it had 92,197,823 ordinary shares outstanding, alongside a small ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback